跳至主要内容
临床试验/NCT06346483
NCT06346483进行中(未招募)不适用

Comparison of Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Without Moses 2.0 Pulse Modulation

Northwestern University2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年6月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
150
试验地点
2
主要终点
Operative time

研究概览

简要总结

The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates.

Currently Moses 2.0 laser technology is FDA approved and currently used in practice since 2021. No study to this date has compared Moses 2.0 without pulse modulation laser technology to Moses 2.0 with pulse modulation laser technology.

The study will be including kidney and ureteral stones (a kidney stone located in the tube between the kidney and the bladder) that are 6mm and greater, but less than 20 mm in size undergoing ureteroscopic treatment. High powered lasers are used for "dusting". Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.

详细描述

On the day of surgery, the treatment assigned to the patient will be determined by chance, like flipping a coin. Neither the patient nor the study doctor will choose the treatment type. Each patient will have an equal chance of being given either surgical treatment. One group will have stones treated with high powered laser dusting with Moses 2.0 pulse modulation and the dust produced will pass spontaneously through the urine. The other group will have stones treated with standard of care high power laser fragmentation and the dust produced will pass spontaneously through the urine. The surgical procedure will not differ from the treatment a patient would receive if he/she were not in this study.

8 to 12 weeks after surgery, participants will undergo a standard of care renal bladder ultrasound (RBUS) and Kidney Ureter Bladder Abdominal X-ray (KUB) to evaluate for stones and hydronephrosis, which is swelling of the kidney due to build-up of urine.

If there are abnormal findings on the RBUS or KUM at the 8 to 12 week follow-up, participants will be asked to return to the urology clinic and may have to repeat imaging to ensure participants did not develop a postoperative condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing ureteroscopy and laser lithotripsy
  • Stone size ≥8 but < 20 mm in the proximal ureter or kidney. Multiple stones ≤4 are allowed. Bilateral surgeries are allowed
  • Willing to sign informed consent

排除标准

  • Staged surgery
  • Nephrocalcinosis
  • Participant is less than 18 years of age
  • Inability to provide informed consent
  • Members of vulnerable patient populations

研究组 & 干预措施

Moses 2.0 arm

Active Comparator

Ureteroscopy with high powered holmium laser lithotripsy with Moses 2.0 pulse modulation.

Ureteral dusting settings: 0.2-0.3x60 Hz (not to exceed 20 W) Renal dusting settings: 0.2-0.3 J x 120 Hz (not to exceed 40 W)

干预措施: Dusting with Moses 2.0 Modulation (Procedure)

Moses 2.0 arm

Active Comparator

Ureteroscopy with high powered holmium laser lithotripsy with Moses 2.0 pulse modulation.

Ureteral dusting settings: 0.2-0.3x60 Hz (not to exceed 20 W) Renal dusting settings: 0.2-0.3 J x 120 Hz (not to exceed 40 W)

干预措施: Moses 2.0 Modulation (Other)

Standard High-powered arm

Active Comparator

Ureteroscopy with high powered holmium laser lithotripsy without Moses 2.0 pulse modulation.

Ureteral dusting settings: 0.2-0.3 x 60 Hz (not to exceed 20 W) Renal dusting settings: 0.2-0.5 J x 80 Hz standard (not to exceed 40 W)

干预措施: Dusting without Moses 2.0 Modulation (Procedure)

结局指标

主要结局

Operative time

时间窗: Day of procedure

Total amount of time (in minutes) taken to complete the procedure.

Stone Free Rate

时间窗: 6-8 weeks post procedure

This is measured by KUB and Renal bladder ultrasound that is post-operative standard of care. Stone free is defined as no stone fragments seen on KUB or RBUS. If there are hyperechoic fragments seen on RBUS but not KUB and the stone analysis was not uric acid, the patient will be considered stone free. The investigators will also calculate a clinically stone free rate (\< 4mm residual fragments allowed). The Stone Free Rate assessments by the investigators will highlight the rate, or ratio of patients who are stone free and patients who are not stone free after procedure.

次要结局

  • Lasing time(Day of procedure)
  • Detection of postoperative strictures(12 weeks)
  • Total laser energy (kJ)(Day of procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amy Krambeck

Professor of Urology

Northwestern University

研究点 (2)

Loading locations...

相似试验